In summary, our study revealed that Setd2 deficiency directly enhanced the recruitment and reprogramming of neutrophils, thereby facilitating immune escape and fostering tumor progression by inhibiting cytotoxicity of CD8+ T cells. This evidence concerns the gene SETD2 and neoplasm.